UK medical robotics group CMR Surgical has put itself up for sale, seeking a valuation of as much as $4bn as the company ...

Financial Times reports today that surgical robot maker CMR Surgical has brought on advisors to explore a potential sale.

CMR is anticipating the broadening of its clinical footprint through two ongoing trials, a multi-centre prospective study of Versius in paediatric surgery and a transoral robotic surgery (TORS ...

CMR’s robot will also compete on price, Slack said. Slack discussed the Versius system’s attributes and the advantages and challenges of robotic-assisted surgery in a conversation with MedTech ...

CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital The latest funding will fuel the global commercialisation of its ...

The AHA predicts the robotic surgery market will change in three major ways this ... a number of notable companies have earned FDA clearance for new robotic systems, including CMR Surgical, ...

“Robot-assisted surgery is crucial to the future of high ... in 2024 and is forecast to reach $9.2bn by 2034. Medtronic and CMR Surgical have emerged as competitors to Intuitive’s market ...

Oct 15 (Reuters) - UK-based medical device maker CMR Surgical said on Tuesday that the U.S. Food and Drug Administration has cleared the upgraded version of its surgical robot to be used in gall ...

CMR is also actively expanding its clinical footprint with two ongoing clinical trials: a pioneering paediatrics study, which is the world’s first multicentre prospective trial on the use of Versius ...